We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry and Trade Groups Weigh in Heavily on FDA’s Microbiological Contamination Draft Guidance
Industry and Trade Groups Weigh in Heavily on FDA’s Microbiological Contamination Draft Guidance
Drugmakers are not pleased with the FDA’s draft guidance on microbiological contamination, published in September to help manufacturers control microbiological contamination of their nonsterile drugs (NSDs).